Brought to you by:
Optimizing acute limb ischemia treatment with a percutaneous-first approach
This advertorial is sponsored by Penumbra. Acute limb ischemia (ALI) management is evolving as new thrombectomy technologies expand the role of endovascular intervention. Jayer Chung, MD, Professor and Medical Director in the Division of Vascular Surgery and Endovascular Therapy at…
Medtronic announces first commercial use of Liberant thrombectomy system
Medtronic has announced the first commercial use of its Liberant thrombectomy system, which is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems. Medtronic notes that Liberant expands the…
InterVene receives US FDA 510(k) clearance for Recana thrombectomy system
InterVene recently announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the Recana thrombectomy catheter system, which is designed for the treatment of venous in-stent restenosis and native vessel obstructions. A press release notes…
SYMPHONY-PE trial demonstrates positive efficacy, efficiency, and safety results
Imperative Care has announced efficacy and safety results from the pivotal SYMPHONY-PE trial evaluating the company’s Symphony thrombectomy system in the treatment of acute pulmonary embolism (PE). Results of the SYMPHONY-PE trial were presented in a late-breaking session at the…
Imperative Care announces FDA clearance for Symphony thrombectomy system
Imperative Care has today announced Food and Drug Administration (FDA) 510(k) clearance of its Symphony thrombectomy system to treat pulmonary embolism (PE). This clearance expands the use of Symphony—previously for the treatment of venous thrombosis—to now include PE, providing a…
Inari Medical, now part of Stryker, launches InThrill thrombectomy system
Inari Medical—now part of Stryker—has announced the launch of its next-generation InThrill thrombectomy system. The company stated in a recent press release that this is the “first and only purpose-built” small vessel and arteriovenous (AV) access thrombectomy system that can…
First patient treated with InterVene’s Recana thrombectomy catheter system
InterVene announced today that the first patient has been treated with its Recana thrombectomy catheter system for venous in-stent restenosis (ISR). The company shares in a press release that Recana is the first fully integrated mechanical thrombectomy system designed specifically…
Penumbra’s STORM-PE randomized trial completes enrollment
Penumbra has announced the completion of enrollment in the STORM-PE clinical trial. The pivotal, prospective, multicenter randomized controlled trial enrolled 100 patients to evaluate computer assisted vacuum thrombectomy (CAVT) using Penumbra’s Lightning Flash plus anticoagulation versus anticoagulation alone for the treatment…
New THRIVE data on CAVT technology for acute limb ischemia show ‘fewer complications, hospital resource use’
Recent THRIVE study data show that Penumbra’s computer-assisted vacuum thrombectomy (CAVT) technology not only has the potential to improve outcomes for lower extremity acute limb ischemia (LE-ALI) patients, but may also reduce healthcare resource use, thus potentially lowering overall costs…
Imperative Care announces completion of enrollment in the SYMPHONY-PE study
Imperative Care has announced the completion of patient enrollment in its SYMPHONY-PE study, a pivotal investigational device exemption (IDE) trial evaluating the safety and efficacy of the company’s Symphony thrombectomy system for the treatment of acute pulmonary embolism (PE). Designed…